The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2017

Filed:

Nov. 05, 2013
Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

Charlotte Beau-Larvor, Jonzier Epagny, FR;

Liliane Goetsch, Ayze, FR;

Nicolas Boute, Cernex, FR;

Assignee:

PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/40 (2006.01); A61K 47/48 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 47/48469 (2013.01); A61K 47/48561 (2013.01); C07K 16/2863 (2013.01); C07K 16/30 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01);
Abstract

The present invention relates to novel antigen binding proteins, in particular monoclonal antibodies, capable of binding to the protein Axl as well as the amino and nucleic acid sequences coding for said proteins. From one aspect, the invention relates to novel antigen binding proteins, or antigen binding fragments, capable of binding to Axl and, by inducing internalization of Axl, being internalized into the cell. The invention also comprises the use of said antigen binding proteins as addressing products in conjugation with other anti-cancer compounds, such as toxins, radio-elements or drugs, and the use of same for the treatment of certain cancers.


Find Patent Forward Citations

Loading…